BRTX vs PG · rev $401.0K vs P/E 25, rev $84.28B
BioRestorative Therapies Inc (BRTX) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
BRTX currently screens at market cap $10.2M. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the BRTX and PG stock pages for the full models.
Not investment advice.